Compare S&P500 ETF (SPY) vs Stryker Corporation (SYK) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
S&P500 ETF vs Stryker Corporation — how do they compare? S&P500 ETF trades at $778.54 (market cap $821.54B), while Stryker Corporation trades at $277.33 (market cap $106.24B). The key difference: S&P500 ETF is far larger — about 7.7× Stryker Corporation's market cap, and Stryker Corporation pays a 1.27% dividend while S&P500 ETF pays none. Which is the better fit depends on your goals — on Pluang, investors hold S&P500 ETF for 205 Days and Stryker Corporation for 21 Days on average.
| SPY | SYK | |
|---|---|---|
Market Cap | $821.54B | $106.24B |
Volume | 40,070,358 | 2,982,001 |
52-Week High | $779.14 | $388.35 |
52-Week Low | $631.99 | $269.75 |
Typical Hold Time | 205 Days | 21 Days |
Sector | — | Health |
Enterprise Value | — | $117.70B |
Dividend Yield | — | 1.27% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
SPY, the SPDR S&P 500 ETF, trades at $778.54, up 0.16% on the day, with a bullish technical signal driven by moving averages. The ETF is positioned near resistance at $777, with support at $771. Recent news highlights mixed sentiment, with some articles noting strong profit growth expectations for the S&P 500 in 2026 but potential headwinds from margin debt and slowing growth forecasts for 2027.
The outlook for SPY remains tied to broader market trends, with opportunities from potential year-end rallies and strong corporate earnings, but risks include macroeconomic volatility and elevated valuations. Investor sentiment is cautious amid warnings about market collapses and shifting profit growth projections.
Stryker (SYK) trades at $277.33, up 0.7% on the day, amid a mixed technical and fundamental backdrop. The stock shows a bearish technical signal with key support at $274 and resistance at $279, while fundamentals remain solid with a 14.43% net income margin and strong analyst consensus. Recent news highlights ongoing legal scrutiny related to a manufacturing issue disclosed in September 2026, which caused an 8.8% stock drop, but the company continues to innovate with product launches like Prophecy surgical planning.
The outlook for SYK is cautiously optimistic, with a consensus price target of $368.11 implying significant upside. Investment opportunities include robust profitability and growth in medical technology, but risks persist from legal investigations and potential operational disruptions. Investors should weigh strong analyst support against near-term sentiment headwinds.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About S&P500 ETF
The ETF is designed to track the performance of the securities and the stocks in the S&P 500 Index. To maintain the composition and weightings, the advisor adjusts the ETF from time to time to conform to periodic changes in the index target.
Read more on SPY →About Stryker Corporation
Stryker is a global leader in medical technology, specializing in Orthopaedics, MedSurg, and Neurotechnology. It is renowned for its highly decentralized business model, which empowers 22 specialized business units to drive innovation and category leadership. With its market-leading Mako SmartRobotics™ platform and a relentless M&A strategy, Stryker provides a comprehensive ecosystem of connected surgical tools, implants, and digital solutions that improve both clinical and financial outcomes for hospitals worldwide.
Read more on SYK →
